{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:30:32Z","timestamp":1772307032129,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ygyno.2009.05.044","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T10:23:48Z","timestamp":1245925428000},"page":"208-212","source":"Crossref","is-referenced-by-count":26,"title":["Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia"],"prefix":"10.1016","volume":"116","clinical-trial-number":[{"clinical-trial-number":"nct00075569","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Koenraad","family":"Van Doorslaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Reimers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgeniy Y.","family":"Studentsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2009.05.044_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2009.05.044_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib3","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/522864","article-title":"Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection","volume":"196","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ygyno.2009.05.044_bib4","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2009.05.044_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2009.05.044_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.AOG.0000114983.11562.08","article-title":"High-grade squamous intraepithelial lesions: abbreviating posttreatment surveillance","volume":"103","author":"Skinner","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cncr.23747","article-title":"Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985\u20132003","volume":"113","author":"Copeland","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2009.05.044_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/JPM.2007.001","article-title":"Cervical surgery and preterm birth","volume":"35","author":"Sadler","year":"2007","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.ygyno.2009.05.044_bib9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.67.3.1373-1384.1993","article-title":"Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation","volume":"67","author":"Griep","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1196\/annals.1352.016","article-title":"Strategies for human papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes","volume":"1056","author":"Govan","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ygyno.2009.05.044_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.cco.0000174038.92526.29","article-title":"Vaccine strategies for human papillomavirus-associated cancers","volume":"17","author":"Kadish","year":"2005","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ygyno.2007.04.038","article-title":"Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III","volume":"106","author":"Einstein","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1365-2249.2000.01293.x","article-title":"Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guerin (BCG) hsp65 and HPV16 E7","volume":"121","author":"Chu","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1128\/JVI.72.1.32-41.1998","article-title":"Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro","volume":"72","author":"McCarthy","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1128\/JCM.40.5.1755-1760.2002","article-title":"Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus","volume":"40","author":"Studentsov","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib16","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1074\/jbc.274.9.5810","article-title":"The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes","volume":"274","author":"Joyce","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2009.05.044_bib17","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/JCM.41.7.2827-2834.2003","article-title":"Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses","volume":"41","author":"Studentsov","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00128360-200501000-00007","article-title":"Interobserver agreement for colposcopy quality control using digitized colposcopic images during the ALTS trial","volume":"9","author":"Ferris","year":"2005","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2009.05.044_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0029-7844(97)00343-8","article-title":"Colposcopic regression patterns in high-grade cervical intraepithelial neoplasia","volume":"90","author":"Brewer","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.22176","article-title":"Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia","volume":"120","author":"Einstein","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.05.044_bib21","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.4049\/jimmunol.172.6.3415","article-title":"Myeloid differentiation factor 88 is required for cross-priming in vivo","volume":"172","author":"Palliser","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1074-7613(00)80179-X","article-title":"A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins","volume":"12","author":"Cho","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ygyno.2009.05.044_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2007.05.038","article-title":"A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia","volume":"106","author":"Roman","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4049\/jimmunol.156.2.873","article-title":"Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24","volume":"156","author":"Suzue","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jcp.2004.025072","article-title":"A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions","volume":"58","author":"Bais","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib26","doi-asserted-by":"crossref","first-page":"24147","DOI":"10.1155\/2007\/24147","article-title":"Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(\u2212) controls","volume":"2007","author":"Bais","year":"2007","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ygyno.2009.05.044_bib27","first-page":"350","article-title":"Role of IL-10 in immune suppression in cervical cancer","volume":"44","author":"Bhairavabhotla","year":"2007","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.ygyno.2009.05.044_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2007.03468.x","article-title":"Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia","volume":"150","author":"Visser","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ygyno.2009.05.044_bib29","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/ijc.21673","article-title":"Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia","volume":"118","author":"Visser","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.05.044_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-4-8","article-title":"Papanicolaou smears and cervical inflammatory cytokine responses","volume":"4","author":"Passmore","year":"2007","journal-title":"J. Inflamm. (Lond)"},{"key":"10.1016\/j.ygyno.2009.05.044_bib31","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1086\/315514","article-title":"Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix","volume":"181","author":"Lawn","year":"2000","journal-title":"J. Infect. Dis."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809004181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809004181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T19:57:55Z","timestamp":1685044675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809004181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0090825809004181"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.05.044","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}